Gary R. Lichtenstein
- Genetics top 2%
- Epidemiology top 5%
- Immunology top 5%
- Surgery top 10%
- Oncology top 10%
- Co-authors
- Brian G. FeaganRobert B. SteinWilliam J. SandbornMichael A. KammKristen O. ArseneauFaten AberraFabio CominelliRoger B. Cohen
- Topics
- Inflammatory Bowel Disease (96 papers)Microscopic Colitis (69 papers)Biosimilars and Bioanalytical Methods (12 papers)
- Cited by
- GeneticsGastroenterologyEpidemiology
- Journals
- SHILAP Revista de lepidopterologíaGastroenterologyThe American Journal of Gastroenterology
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Gary R. Lichtenstein
114 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 104
- Genetics 1.1k
- Epidemiology 735
- Immunology 441
- Surgery 405
- Oncology 260
Countries citing papers authored by Gary R. Lichtenstein
This map shows the geographic impact of Gary R. Lichtenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Lichtenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Lichtenstein more than expected).
Fields of papers citing papers by Gary R. Lichtenstein
This network shows the impact of papers produced by Gary R. Lichtenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Lichtenstein. The network helps show where Gary R. Lichtenstein may publish in the future.
Co-authorship network of co-authors of Gary R. Lichtenstein
This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Lichtenstein. A scholar is included among the top collaborators of Gary R. Lichtenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Lichtenstein. Gary R. Lichtenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 10 | |
| 7 | 8 | |
| 8 | 18 | |
| 9 | 42 | |
| 10 | 11 | |
| 11 | 59 | |
| 12 | 48 | |
| 13 | 7 | |
| 14 | 48 | |
| 15 | 29 | |
| 16 | 78 | |
| 17 | 61 | |
| 18 | 6 | |
| 19 | 23 | |
| 20 | 23 |
About Gary R. Lichtenstein
Gary R. Lichtenstein is a scholar working on Genetics, Gastroenterology and Epidemiology, having authored 118 papers that have together received 2.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (96 papers), Microscopic Colitis (69 papers) and Biosimilars and Bioanalytical Methods (12 papers). The work is most often cited by research in Genetics (1.1k citations), Gastroenterology (131 citations) and Epidemiology (735 citations). Gary R. Lichtenstein has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Brian G. Feagan, Robert B. Stein, William J. Sandborn, Michael A. Kamm, Kristen O. Arseneau, Faten Aberra, Fabio Cominelli, Roger B. Cohen, Stephen J. Bickston and Russell D. Cohen. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.